Mark L Pacala Receives Stock Award at Oncology Institute Inc (TOI) — SEC Form 4, Nov 24, 2025

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Mark L Pacala

Director

TXN 2025-11-20 · FILED 2025-11-24

Equity Position 257K sh 174,971 → 256,761

Equity Change +46.7% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Oncology Institute Inc

TOI CIK 0001799191

Reporting Owner

Name	Relationship
Mark L Pacala CIK 0001321250	Director

Mark L Pacala at Oncology Institute Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $200,000

More from this insider at Oncology Institute Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2025-11-20	A - Award/Grant	46,296 A	$0.00	—	221,267	Direct
Common StockF2	2025-11-20	A - Award/Grant	35,494 A	$0.00	—	256,761	Direct

Footnotes (2)

F1: Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date. Show more
F2: Represents restricted stock units that were fully vested upon grant. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Oncology Institute Inc

GET /v1/forms/4/0001553350-25-000144 API docs